Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_assertion type Assertion NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_head.
- NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_provenance.
- NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_assertion evidence source_evidence_curated NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_provenance.
- NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_assertion SIO_000772 17330099 NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_provenance.
- NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_assertion wasDerivedFrom ctd_human-20130708 NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_provenance.
- NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_assertion wasGeneratedBy ECO_0000218 NP13040.RA3O6q4HpeQg53bp916E1QQsMyIna6FQtuim5iPmFJtFs130_provenance.